Regulatory News
Thursday, January 12, 2017
BRIEF-Pluristem completes patient enrollment in phase II trial in intermittent claudication
* Pluristem completes patient enrollment in a large
multinational phase II trial in intermittent claudication
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment